| Kyle J Alliman, MD | |
|
6200 Westown Pkwy, West Des Moines, IA 50266-7705 | |
| (800) 542-7956 | |
| (641) 754-6245 |
| Full Name | Kyle J Alliman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 20 Years |
| Location | 6200 Westown Pkwy, West Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437360351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 39020 (Iowa) | Primary |
| 207W00000X | Ophthalmology | ME101982 (Florida) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 39020 (Iowa) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wolfe Clinic Inc | 8628979291 | 47 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells-kidney, brain, heart or skin, for example. One class, pluripotent stem cells, has the capacity to turn into virtually any cell type in the body, making them a focal point in the development of cell therapies, the conquering of age-old diseases or even regrowing defective body parts.
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
An FDA advisory panel on Monday voiced concern over the potential risks of conducting early HIV vaccine trials among teenagers in the U.S., Bloomberg reports. According to the panel, although such trials are justified in countries where HIV/AIDS is spreading more quickly, the risks might not outweigh the benefits in the U.S.
› Verified 7 days ago
| Entity Name | Wolfe Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477532174 PECOS PAC ID: 8628979291 Enrollment ID: O20040116000276 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells-kidney, brain, heart or skin, for example. One class, pluripotent stem cells, has the capacity to turn into virtually any cell type in the body, making them a focal point in the development of cell therapies, the conquering of age-old diseases or even regrowing defective body parts.
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
An FDA advisory panel on Monday voiced concern over the potential risks of conducting early HIV vaccine trials among teenagers in the U.S., Bloomberg reports. According to the panel, although such trials are justified in countries where HIV/AIDS is spreading more quickly, the risks might not outweigh the benefits in the U.S.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle J Alliman, MD 309 E Church St, Marshalltown, IA 50158-2946 Ph: (641) 754-6262 | Kyle J Alliman, MD 6200 Westown Pkwy, West Des Moines, IA 50266-7705 Ph: (800) 542-7956 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells-kidney, brain, heart or skin, for example. One class, pluripotent stem cells, has the capacity to turn into virtually any cell type in the body, making them a focal point in the development of cell therapies, the conquering of age-old diseases or even regrowing defective body parts.
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
An FDA advisory panel on Monday voiced concern over the potential risks of conducting early HIV vaccine trials among teenagers in the U.S., Bloomberg reports. According to the panel, although such trials are justified in countries where HIV/AIDS is spreading more quickly, the risks might not outweigh the benefits in the U.S.
› Verified 7 days ago
Dr. Christina Gillmor, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6200 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-223-8685 | |
Frederick Royce Blodi, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5901 Westown Pkwy Ste 200, West Des Moines, IA 50266 Phone: 515-225-3546 Fax: 515-224-5946 | |
Douglas R Casady, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6200 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-223-8685 Fax: 515-223-5468 | |
David D Saggau, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6200 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-233-8685 Fax: 515-223-5468 | |
Derek P Bitner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6200 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-223-8685 Fax: 515-223-5468 | |
Dr. Chris W. Schmidt, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1729 S 40th Ct, West Des Moines, IA 50265 Phone: 217-714-1421 | |
Mr. Todd Whitney Heilskov, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1501 50th St, Ste 133, West Des Moines, IA 50266 Phone: 575-222-6400 Fax: 515-222-6406 |